Search Results
Dec 10, 2025, 06:15 ET Uranium Energy Corp Reports Results for First Quarter of Fiscal 2026
Total Cost Per PoundJ=G+H+I$ 34.35Safe
More news about: Uranium Energy Corp
Dec 09, 2025, 21:21 ET PR Newswire Dukung Era AI, Sambut Masa Depan Penelusuran dan Penemuan Informasi Berbasiskan AI
https://www.prnewswire.com/amplify-platform/.Pertanyaan UmumT: What is E-E-A-T?J: E-E-A-T merupakan singkatan dari Experience, Expertise, Authoritativeness, dan Trustworthiness (Pengalaman Pembaca, Keahlian,
More news about: PR Newswire
Dec 09, 2025, 19:26 ET Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
References[1]. J Transl Int Med. 2022;10(2):134-145[2].
More news about: Innovent Biologics
Dec 09, 2025, 17:28 ET Xcaliber International General Counsel Eric Estes Named a 2026 Legends in Law Honoree
Senior Vice President, General Counsel and Corporate Secretary, Lockheed Martin Corporation; Elaine Mandelbaum, General Counsel, Interactive Brokers LLC; J. Kevin McCarthy, General Counsel, BNY; Brent McIntosh, Chief Legal Officer & Corporate Secretary, Citi; Steve McManus, Chief Legal Officer, State
More news about: Xcaliber International
Dec 09, 2025, 16:15 ET UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF CALIFORNIA
addresses are:for Settling Stockholders:RIGRODSKY LAW, P.A.Timothy J. MacFall825 East Gate Boulevard, Suite 300 Garden City, NY 11530 Tel: (516) 683-3516
More news about: Origin Materials, Inc.
Dec 09, 2025, 16:01 ET Collective Mining Significantly Expands the Apollo System to the North by up to 450 Metres Through Multiple Broad Intercepts Representing a New Hanging Wall Vein Zone
American and TSX under the trading symbol "CNL".Qualified Person (QP) and NI43-101 DisclosureDavid J Reading is the designated Qualified Person for this news release within the meaning of National Instrument 43-101 ("NI 43-101") and has reviewed and verified
More news about: Collective Mining Ltd.
Dec 09, 2025, 16:00 ET Cirius Therapeutics to Highlight Cardiometabolic Benefits of CIR-0602K at Global Cardiovascular Clinical Trialists (CVCT) Forum 2025
8-10 at the Mayflower Hotel in Washington, DC. 1 Giugliano, et al., Diab Obes Metab, 2020; 2 Harrison, et al., J Hepat, 2020; 3 Despres, et al., NEJM, 1996; 4 Kumar, et al., Diab Vasc Dis Res, 2019; 5 Harrison,
More news about: Cirius Therapeutics
Dec 09, 2025, 12:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
Technology. 2025;28(C):101079. doi:10.1016/j.iotech.2025.101079.2 Machiraju D, et al. J Exp Clin Cancer Res. 2025;44:213. doi:10.1186/s13046-025-03451-2.3 Ramelyte E, Koett, J, et al. Clinical Cancer Research. Accepted.TrilliumBiO Contact:Olivia McCannPR
More news about: TrilliumBiO
Dec 09, 2025, 11:19 ET Journal of Cardiac Failure December Issue Showcases Innovations in Transplant Care, Digital Therapeutics, and Global Heart Failure Treatment Strategies
JCF co-editors-in-chief Robert J. Mentz, MD and Anuradha Lala, MD "These featured articles illustrate how innovation is happening on many fronts: in transplant medicine, digital therapeutics,
More news about: Heart Failure Society of America
Dec 09, 2025, 11:03 ET Pew Funds 7 New Biomedical Research Collaborations
Michael J. Rust, Ph.D., 2014 Pew biomedical scholar, University of Chicago
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew fomenta 7 novas colaborações em pesquisa biomédica
Michael J. Rust, Ph.D., da classe de 2014 do Pew biomedical scholar, University of Chicago
More news about: The Pew Charitable Trusts
Dec 09, 2025, 11:03 ET Pew financia 7 nuevas colaboraciones en investigación biomédica
Michael J. Rust, Ph.D., académico del programa Pew en biomedicina del año 2014, Universidad de Chicago
More news about: The Pew Charitable Trusts
Dec 09, 2025, 10:02 ET Former Under Secretary of the Navy Victor Minella Joins FedLearn Board of Advisors
Dr. J. Keith Dunbar, FedLearn founder and CEO. "Mr. Minella's distinguished service in the Navy, paired with deep experience across intelligence and security,
More news about: FedLearn
Dec 09, 2025, 09:15 ET Former U.S. Attorneys Warn of Unprecedented Threat to America's Justice System at Speak Up for Justice Forum on December 15
Executive Committee includes the following distinguished members: Judge Beth Bloom, Judge Esther Salas, Judge Karoline Mehalchick, Judge Leo Gordon, Karl J. Sandstrom, and Paul Kiesel.Media Contacts:Kathy FowlerEmail:
More news about: Kiesel Law
Dec 09, 2025, 09:03 ET CONSUMING TREE NUTS AS SNACKS REDUCES FOOD CRAVINGS AND IMPROVES DIET QUALITY IN MILLENNIALS AT RISK FOR METABOLIC SYNDROME
were part of a 7-day weight maintenance menu that repeated throughout the study duration of 16 weeks.According to Principal Investigator, Heidi J. Silver, R.D., M.S., Ph.D., Research Professor of Medicine at Vanderbilt University Medical Center, "Compared to those who consumed the high carbohydrate
More news about: International Tree Nut Council Nutrition Research & Education Foundation
Dec 09, 2025, 09:00 ET WatchMeGrow Appoints PB&J TV Founder Bobby Franzo as Chief Executive Officer
Mr. Franzo joins WatchMeGrow after more than a decade as Founder and CEO of PB&J TV, one of the most trusted video SaaS platforms in the early education, youth enrichment and pet care sectors. Under his leadership, PB&J TV grew from a startup into a national provider known for reliability, customer
More news about: WatchMeGrow
Dec 09, 2025, 09:00 ET TrilliumBiO and Oncobit Partner to Bring Novel Uveal Melanoma Monitoring Solution to the U.S.
Technology. 2025;28(C):101079. doi:10.1016/j.iotech.2025.101079.2 Machiraju D, et al. J Exp Clin Cancer Res. 2025;44:213. doi:10.1186/s13046-025-03451-2.3 Ramelyte E, Koett, J, et al. Clinical Cancer Research. Accepted.TrilliumBiO Contact:Olivia McCannPR
More news about: TrilliumBiO
Dec 09, 2025, 08:30 ET FLAGSTAR PRIVATE BANK EXPANDS WEALTH CAPABILITIES, APPOINTS LEADERS TO OVERSEE THEM; LAUNCHES REGIONAL AND SECTOR FOCUSED OPERATING MODEL
upper Midwest, along with a significant presence in the growth markets of Florida and the Southwest.Investor Contact: Salvatore J. DiMartino516-683-4286Media Contact:Steven Bodakowski248-312-5872
More news about: Flagstar Bank, N.A.
Dec 09, 2025, 08:00 ET Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
10.1200/OP.22.001807 Sharma, S., Doshi, G., Shumway, N., Schaefer, E., Dave, N., Marcus, A., Dyson, B., Derman, B., Essell, J., Ascha, M., Calkins, G., Neiman, J., Kwiatkowsky, L., & Kolodziej, M. (2025). Application of the remote therapeutic monitoring (RTM) platform to optimize adherence
More news about: Canopy
Dec 09, 2025, 08:00 ET PKF O'Connor Davies Releases 2025 Edition of Dental Practices by the Numbers
have relied on our dental industry specialists to provide top-notch tax and consulting advice and support at every stage of their careers," said David J. Goodman, Partner and Dental Practice Leader at PKF O'Connor Davies. "We are grateful to our many clients who provided practice data to make this study
More news about: PKF O’Connor Davies
Dec 09, 2025, 07:45 ET Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
integrated large-scale proteomic data from the Parkinson's Progression Markers Initiative (PPMI), a landmark longitudinal study managed by The Michael J. Fox Foundation that tracks thousands of patients over time to identify biological markers of disease progression, with high-resolution clinical phenotyping
More news about: Lunai Bioworks Inc.
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
American Society of Hematology Annual Meeting. Accessed December 2025.2 Mateos, M.V., Moreau, P., Garfall, A. L., van de Donk, N. W. C. J., et al. (2025) Teclistamab plus daratumumab versus standard regimens in relapsed or refractory multiple myeloma: MajesTEC-3 Trial Results. The New England
More news about: Johnson & Johnson
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
therapies in mantle cell lymphoma. J Hematol Oncol. 2020;13(1):79. Published 2020 Jun 17. doi:10.1186/s13045-020-00914-1Gu D, Tang H, Wu J, Li J, Miao Y. Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies. J Hematol Oncol. 2021;14(1):40. Published
More news about: Eli Lilly and Company
Dec 09, 2025, 01:19 ET Voranigo® (Vorasidenib) von Servier erhält Prix Galien Awards in mehreren Regionen
Mellinghoff, I. K., van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., Ducray, F., Umemura, Y., Nabors, B., Holdhoff, M., Hottinger, A. F., Arakawa, Y., Sepulveda, J. M., Wick, W., Soffietti, R., ... Cloughesy, T.
More news about: Servier
Dec 09, 2025, 01:01 ET Servier の Voranigo®（ボラシデニブ）が複数地域でプリ・ガリアン賞を受賞
Mellinghoff, I. K., van den Bent, M. J., Blumenthal, D. T., Touat, M., Peters, K. B., Clarke, J., Mendez, J., Yust-Katz, S., Welsh, L., Mason, W. P., Ducray, F., Umemura, Y., Nabors, B., Holdhoff, M., Hottinger, A. F., Arakawa, Y., Sepulveda, J. M., Wick, W., Soffietti, R., … Cloughesy, T. F.（2023年）IDH1
More news about: Servier